Global Spinal Cord Stimulation Market: Trends & Opportunities (2014-19)

December 2014 | 66 pages | ID: G497E051509EN
Daedal Research

Abstracts

Scope of the Report

The report titled “Global Spinal Cord Stimulation Market: Trends and Opportunities (2014-2019)” provides an in-depth analysis of the global Spinal cord Stimulation market (including medication, surgeries and therapies) with detailed analysis of market sizing and growth. It also assesses the key opportunities and underlying trends in the market and outlines the factors that are and will be driving the growth of the industry in the forecasted period (2014-19). The report also assesses the main types of SCS devices – the rechargeable and non-rechargeable spinal cord stimulation devices. Further, key players of the industry like Boston Scientific Corporation, St. Jude Medical and Medtronic have been profiled and analyzed in the report.

Segment Coverage

• Rechargeable SCS System
• Non-Rechargeable SCS system

Company Coverage

• Boston Scientific
• Nevro
• St. Jude Medical
• Medtronic

Executive Summary

Spinal cord stimulation (SCS) is a pain relief technique that delivers a low-voltage electrical current continuously to the spinal cord to block the sensation of pain. SCS is the most commonly used implantable neuro-stimulation technology for management of pain syndromes. The growth of the global Spinal cord Stimulation market is driven by a number of factors that include rise in ageing demographics, rising healthcare expenditure per capita, growing cases of obesity and increasing number of failed surgeries. Acknowledging these factors, it could be said that the Spinal cord Stimulation market business will certainly gain importance in the years to come.

Strict regulations, environment issues, dearth of expertise and trained healthcare workers and several other issues pose major challenge to the growth of this business. Major trends prevailing in the spinal cord stimulation market are advancement in spine surgery, changing surgeon preferences, mergers & acquisitions and incidence of pain conditions in the US households.

Contents

1. EXECUTIVE SUMMARY

2. SPINAL CORD INJURIES AND STIMULATION: AN INTRODUCTION

2.1 Spinal Cord Stimulator

3. GLOBAL SPINAL CORD STIMULATION MARKET ANALYSIS

3.1 Global Spinal Cord Stimulation Market: Size and Growth

4. SPINAL CORD STIMULATION MARKET: SEGMENT ANALYSIS

4.1 Rechargeable versus Non Rechargeable

5. THE US SPINAL CORD STIMULATION MARKET

5.1 The US Spinal Cord Stimulation Market Share
5.2 The US Spinal Cord Stimulation Market Analysis
5.3 The US Chronic Pain Market Analysis
  5.3.1 US Chronic Pain Market: Size & Growth
  5.3.2 US Chronic Pain Market Forecast: Size & Growth

6. GLOBAL SPINAL CORD STIMULATION MARKET DYNAMICS

6.1 Growth Drivers
  6.1.1 Growing Cases of Obesity
  6.1.2 Rising Healthcare Expenditures
  6.1.3 Rise in Aging Demographics
6.2 Market Challenges

7. GLOBAL SPINAL CORD STIMULATION MARKET TRENDS

7.1 Advancements in Spine Surgery
7.2 Changing Surgeon Preferences
7.3 Mergers and Acquisitions
7.4 Incidence of pain conditions in the US households

8. COMPETITIVE LANDSCAPE: SPINAL CORD STIMULATION MARKET

9. COMPANY PROFILES: SPINAL CORD STIMULATION MARKET

9.1 Boston Scientific Corporation (BSX)
  9.1.1 Business Overview
  9.1.2 Financial Overview
  9.1.3 Business Strategies
9.2 St. Jude Medical (SJM)
  9.2.1 Business Overview
  9.2.2 Financial Overview
  9.2.3 Business Strategy
9.3 Medtronic, Inc.
  9.3.1 Business Overview
  9.3.2 Financial Overview
  9.3.3 Business Strategies
9.4 Nevro Corp
  9.4.1 Business Overview
  9.4.2 Financial overview
  9.4.3 Business Strategies

Figures & Tables

LIST OF FIGURES AND TABLES

Figure 1: Side view of Spine
Figure 2: Spinal Cord Stimulator
Table 1: WHO Guidelines for Pain Therapy
Figure 3: Causes of Spinal Cord Injury, 2013
Table 2: Average Yearly Health costs attributed to Spinal Cord Injuries
Figure 4: Global Spinal Cord Stimulation Market, 2008-13, (in US$ billion)
Figure 5: Global Spinal Cord Stimulation Market, 2014E-19E, (in US$ billion)
Figure 6: Global Spinal Cord Stimulation Market- by segment
Figure 7: The US Spinal Cord Stimulation Market- by segment
Figure 8: Australian Spinal Cord Stimulation Market- by segment
Figure 9: Share of the US in Spinal cord stimulation Market, 2013
Figure 10: The US Spinal Cord Stimulation Market- by value, 2008-2013 (In US$ billion)
Figure 11: The US Spinal Cord Stimulation Market- by value, 2014E-2019E (In US$ billion)
Figure 12: US Chronic Pain Market 2009-2013E (in US$ billions)
Figure 13: US Chronic Pain Market 2014F-2019F (in US$ billions)
Figure 14: Global Healthcare Expenditures Per Capita, 2007-2013 (in US$)
Figure 15: World’s Aging population, 2007-13 (in millions)
Table 3: Major Acquisitions in Spine Market
Figure 16: Incidence of Pain in the US (in %)
Table 4: Leading Players of Global Spinal Cord Stimulation Market
Table 5: Comparison of Spinal Cord stimulators of leading Players
Table 6: Spinal Cord Stimulation Industry: Key Players and their product areas
Figure 17: Market Share of leading players of Global SCS, 2013
Table 7: Spinal Cord stimulation Industry: Sales of Leading Companies
Table 8: Products offered by Boston Scientific Corporation
Figure 18: Boston Scientific SCS revenue, FY 2011-13 (in US$ million)
Figure 19: Boston Scientific -Operating Income (consolidated), FY 2011-13 (in US$ million)
Figure 20: Boston Scientific -Revenue by segment, FY 2013 (in US$ million)
Figure 21: Boston Scientific -MedSurg Revenue- by segment, 2013, (in US$ million)
Figure 22: St. Jude - Net Revenue- Spinal Cord Stimulation, FY 2011-13 (in US$ million)
Figure 23: St. Jude- IESD revenue-by Segment wise, FY 2013 (in US$ billion)
Figure 24: Medtronic’s SCS- Net Revenue, FY 2011-13 (in US$ million)
Figure 25: Medtronic Revenue – by segment, FY 2013
Figure 26: Medtronic Revenue – by Sub segment, FY 2013
Figure 27: Nevro’s Net Revenue- SCS, FY 2011-13 (in US$ million)